|
Postmenopausal Hormone Therapy and Cardiovascular Disease in Women The American Heart Association does not advise women to take postmenopausal hormone therapy (PHT, formerly called hormone replacement therapy or HRT) or selective estrogen receptor modulators (SERMs) to reduce the risk of coronary heart disease or stroke.* *American Heart Association. Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update. Circulation. 2007;115:1481-1501. Related AHA Scientific Statements See also: Heart Attack Menopause Oral Contraceptives Pregnancy and Heart Disease Risk Factors and Coronary Heart Disease Stroke Women, Heart Disease and Stroke |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
| |||
| | | ||
